The Klinique Medical Clinic PCL (BKK:KLINIQ)
32.25
+0.25 (0.78%)
Nov 9, 2026, 3:40 PM ICT
BKK:KLINIQ Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, BKK:KLINIQ stock has a consensus rating of "Strong Buy" and an average price target of ฿40.19. The average 1-year stock price forecast is 24.62% higher than the current stock price, while the lowest is ฿34.00 (+5.43%) and the highest is ฿46.00 (+42.64%).
Price Target: ฿40.19 (+24.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BKK:KLINIQ stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 2 | 2 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
4.68B
from 3.56B
Increased by 31.51%
Revenue Next Year
5.43B
from 4.68B
Increased by 16.08%
EPS This Year
2.26
from 1.65
Increased by 37.17%
EPS Next Year
2.64
from 2.26
Increased by 16.50%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.